(Q36677248)

15 August 2017

1 reference

title

Recommendations for the use of methotrexate in juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

15 August 2017

main subject

1 reference

1 reference

1

Tim Niehues

1 reference

15 August 2017

Petra Lankisch

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

347-356

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200608060-00003

15 August 2017

exact match

0 references

cites work

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00148581-200608060-00003

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00148581-200608060-00003

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

21 January 2018

1 reference

12 December 2020

Lymphadenopathy in a patient with systemic onset juvenile chronic arthritis

1 reference

12 December 2020

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

12 December 2020

Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates

1 reference

12 December 2020

Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy

1 reference

12 December 2020

Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis

1 reference

12 December 2020

The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis

1 reference

12 December 2020

Medical management of children with juvenile rheumatoid arthritis

1 reference

12 December 2020

The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.

1 reference

12 December 2020

Pharmacokinetics of oral methotrexate in children.

1 reference

12 December 2020

Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis

1 reference

12 December 2020

Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

1 reference

12 December 2020

Psoriasis, methotrexate, and oligospermia

1 reference

12 December 2020

Reducing toxicity of methotrexate with folic acid

1 reference

12 December 2020

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

1 reference

12 December 2020

Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods

1 reference

12 December 2020

Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?

1 reference

12 December 2020

The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study

1 reference

12 December 2020

Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients

1 reference

12 December 2020

Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.

1 reference

12 December 2020

A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis

1 reference

12 December 2020

Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study

1 reference

12 December 2020

Combinations of conventional disease-modifying antirheumatic drugs

1 reference

12 December 2020

The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions

1 reference

12 December 2020

Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study

1 reference

12 December 2020

The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate

1 reference

12 December 2020

Impotence in three rheumatoid arthritis patients treated with methotrexate

1 reference

12 December 2020

Leflunomide or methotrexate for juvenile rheumatoid arthritis

1 reference

12 December 2020

Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study

1 reference

12 December 2020

Use of methotrexate in juvenile idiopathic arthritis

1 reference

12 December 2020

Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy.

1 reference

12 December 2020

Duration of methotrexate treatment until partial and total remission of refractory juvenile rheumatoid arthritis

1 reference

12 December 2020

Influence of food on the bioavailability of oral methotrexate in children.

1 reference

12 December 2020

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis

1 reference

12 December 2020

Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis

1 reference

12 December 2020

Health care provision in pediatric rheumatology in Germany--national rheumatologic database

1 reference

12 December 2020

Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients

1 reference

12 December 2020

The remarkable spectrum of methotrexate toxicities

1 reference

12 December 2020

Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis

1 reference

12 December 2020

Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

1 reference

12 December 2020

Methotrexate for treating juvenile idiopathic arthritis

1 reference

12 December 2020

Immunoglobulin levels in methotrexate treated paediatric rheumatology patients

1 reference

12 December 2020

Adult and two children with fetal methotrexate syndrome

1 reference

12 December 2020

Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.

1 reference

12 December 2020

Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review

1 reference

12 December 2020

Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders

1 reference

12 December 2020

Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis

1 reference

12 December 2020

Advances in the medical treatment of juvenile rheumatoid arthritis.

1 reference

12 December 2020

A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Toward a better understanding of methotrexate

1 reference

12 December 2020

Intraarticular corticosteroid injection in the management of children with chronic arthritis.

1 reference

12 December 2020

Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics

1 reference

12 December 2020

Prolongation and enhancement of serum methotrexate concentrations by probenecid

1 reference

12 December 2020

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

1 reference

12 December 2020

Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate

1 reference

12 December 2020

The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis

1 reference

12 December 2020

Methotrexate use in rheumatoid arthritis

1 reference

12 December 2020

Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria

1 reference

12 December 2020

A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing

1 reference

12 December 2020

Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in juvenile idiopathic arthritis: answers and questions

1 reference

12 December 2020

Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et al.

1 reference

12 December 2020

Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.

1 reference

12 December 2020

The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis

1 reference

12 December 2020

Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety

1 reference

12 December 2020

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis

1 reference

12 December 2020

Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma

1 reference

12 December 2020

Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.

1 reference

12 December 2020

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

1 reference

12 December 2020

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

1 reference

12 December 2020

Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis

1 reference

12 December 2020

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

1 reference

12 December 2020

[Treatment of chronic polyarthritis with methotrexate 1994--a review]

1 reference

12 December 2020

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother

1 reference

12 December 2020

The use of methotrexate in childhood rheumatic diseases

1 reference

12 December 2020

Pharmacokinetics of subcutaneous methotrexate

1 reference

12 December 2020

The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules

1 reference

12 December 2020

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

12 December 2020

Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate

1 reference

12 December 2020

High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.

1 reference

12 December 2020

10.2165/00148581-200608060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1005229145

0 references

1 reference